Lista de obras - Anna Bonjoch - Dominio Público Uruguay

A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction

artículo científico publicado en 2020

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV

scientific article published on 17 September 2020

Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.

artículo científico publicado en 2001

Association between lipid genetic and immunological status in chronically HIV-infected patients

artículo científico publicado en 2014

Association between polymorphisms in genes involved in lipid metabolism and immunological status in chronically HIV-infected patients

artículo científico publicado en 2014

Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.

artículo científico publicado en 1999

Benefits and concerns of simplification strategies in HIV-infected patients

artículo científico publicado en 2006

Combined Antiretroviral Therapy and Immune Pressure Lead to In Vivo HIV-1 Recombination With Ancestral Viral Genomes

article

Comparison of two different strategies of treatment with zoledronate in HIV-infected patients with low bone mineral density: single dose versus two doses in 2 years

artículo científico publicado en 2015

Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studies

artículo científico publicado en 2005

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.

artículo científico publicado en 2013

Efficacy of Adding Indinavir to Previous Reverse Transcriptase Nucleoside Analogues in Relation to Genotypic and Phenotypic Resistance Development in Advanced HIV-1-Infected Patients ⬇️

artículo científico publicado el 1 de septiembre de 1998

Evaluation of protease inhibitors containing tubes for MS-based plasma peptide profiling studies.

artículo científico publicado en 2014

Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins

High Prevalence of Sarcopenia in HIV-Infected Individuals

article

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

artículo científico publicado en 2010

High prevalence of signs of renal damage despite normal renal function in a cohort of HIV-infected patients: evaluation of associated factors.

artículo científico publicado en 2014

High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.

artículo científico publicado en 2012

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

artículo científico publicado en 2018

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

High-dose saquinavir plus ritonavir: long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response

artículo científico publicado en 1999

Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients

artículo científico

Impact of protease inhibitors on the evolution of urinary markers: Subanalyses from an observational cross-sectional study.

artículo científico publicado en 2016

Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study)

artículo científico publicado en 2014

Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).

artículo científico publicado en 2009

Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients

article

Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.

artículo científico publicado en 1998

Long-term changes in bone mineral density after switching to a protease inhibitor monotherapy in HIV-infected subject

artículo científico publicado en 2015

Management of bone mineral density in HIV-infected patients

artículo científico publicado en 2016

Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial

scholarly article by Ignacio Pérez-Valero et al published 11 June 2018 in Journal of Antimicrobial Chemotherapy

Peak bone mass in young HIV-infected patients compared with healthy controls

artículo científico publicado en 2014

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner

artículo científico publicado en 2014

Potential prescribing issues among older HIV-infected persons in a Mediterranean cohort: Does the current prevalence give cause for concern?

artículo científico publicado en 2020

Prevalence of ischemic heart disease and management of coronary risk in daily clinical practice: results from a Mediterranean cohort of HIV-infected patients

artículo científico publicado en 2014

Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals.

artículo científico publicado en 2017

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity

artículo científico publicado en 2016

Pulse wave velocity as index of arterial stiffness in HIV-infected patients compared with a healthy population

scientific article published on 01 January 2014

Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens

artículo científico publicado en 2002

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study

artículo científico publicado en 2014

Removal of Dolutegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease

artículo científico publicado en 2016

Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.

artículo científico publicado en 2003

Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV-1-infected subjects with dyslipidaemia

artículo científico publicado en 2017

Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals.

artículo científico publicado en 2016

Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels.

artículo científico publicado en 2015

Switching the third drug of antiretroviral therapy to maraviroc in aviraemic subjects: a pilot, prospective, randomized clinical trial

artículo científico publicado en 2013

Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot study.

artículo científico publicado en 2008

Ten-Year Safety with Polyacrylamide Gel Used to Correct Facial Lipoatrophy in HIV-Infected Patients

artículo científico publicado en 2015

Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan

artículo científico publicado en 2012

Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiated.

artículo científico publicado en 2008

Validation of estimated renal function measurements compared with the isotopic glomerular filtration rate in an HIV-infected cohort

artículo científico publicado en 2010

Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individuals

artículo científico publicado en 2017

Viral failure in HIV-infected patients with long-lasting viral suppression who discontinued enfuvirtide

scientific article published on 01 September 2006

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression

artículo científico publicado en 2002

Lista de obras de Anna Bonjoch

A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction

A randomized pilot trial to evaluate the benefit of the concomitant use of atorvastatin and Raltegravir on immunological markers in protease-inhibitor-treated subjects living with HIV

Antiretroviral treatment simplification with nevirapine in protease inhibitor-experienced patients with hiv-associated lipodystrophy: 1-year prospective follow-up of a multicenter, randomized, controlled study.

Association between lipid genetic and immunological status in chronically HIV-infected patients

Association between polymorphisms in genes involved in lipid metabolism and immunological status in chronically HIV-infected patients

Benefit of switching from a protease inhibitor (PI) to nevirapine in PI-experienced patients suffering acquired HIV-related lipodystrophy syndrome (AHL): interim analysis at 3 months of follow-up.

Benefits and concerns of simplification strategies in HIV-infected patients

Combined Antiretroviral Therapy and Immune Pressure Lead to In Vivo HIV-1 Recombination With Ancestral Viral Genomes

Comparison of two different strategies of treatment with zoledronate in HIV-infected patients with low bone mineral density: single dose versus two doses in 2 years

Compromised immunologic recovery in treatment-experienced patients with HIV infection receiving both tenofovir disoproxil fumarate and didanosine in the TORO studies

Early but limited effects of raltegravir intensification on CD4 T cell reconstitution in HIV-infected patients with an immunodiscordant response to antiretroviral therapy.

Efficacy of Adding Indinavir to Previous Reverse Transcriptase Nucleoside Analogues in Relation to Genotypic and Phenotypic Resistance Development in Advanced HIV-1-Infected Patients ⬇️

Evaluation of protease inhibitors containing tubes for MS-based plasma peptide profiling studies.

Ezetimibe, a promising lipid-lowering agent for the treatment of dyslipidaemia in HIV-infected patients with poor response to statins

High Prevalence of Sarcopenia in HIV-Infected Individuals

High prevalence of and progression to low bone mineral density in HIV-infected patients: a longitudinal cohort study

High prevalence of signs of renal damage despite normal renal function in a cohort of HIV-infected patients: evaluation of associated factors.

High rate of reversibility of renal damage in a cohort of HIV-infected patients receiving tenofovir-containing antiretroviral therapy.

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

High risk and probability of progression to osteoporosis at 10 years in HIV-infected individuals: the role of PIs

High-dose saquinavir plus ritonavir: long-term efficacy in HIV-positive protease inhibitor-experienced patients and predictors of virologic response

Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients

Impact of protease inhibitors on the evolution of urinary markers: Subanalyses from an observational cross-sectional study.

Improvement in bone mineral density after switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: two-centre randomized pilot study (OsteoTDF study)

Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).

Long-Term Safety and Efficacy of Nevirapine-Based Approaches in HIV Type 1-Infected Patients

Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.

Long-term changes in bone mineral density after switching to a protease inhibitor monotherapy in HIV-infected subject

Management of bone mineral density in HIV-infected patients

Neurocognitive safety after 96 weeks on dual therapy with atazanavir/ritonavir plus lamivudine: results of the neurocognitive substudy of the SALT randomized clinical trial

Peak bone mass in young HIV-infected patients compared with healthy controls

Polymorphisms in LPL, CETP, and HL protect HIV-infected patients from atherogenic dyslipidemia in an allele-dose-dependent manner

Potential prescribing issues among older HIV-infected persons in a Mediterranean cohort: Does the current prevalence give cause for concern?

Prevalence of ischemic heart disease and management of coronary risk in daily clinical practice: results from a Mediterranean cohort of HIV-infected patients

Prevalence, evolution, and related risk factors of kidney disease among Spanish HIV-infected individuals.

Prospective Study to Assess Progression of Renal Markers after Interruption of Tenofovir due to Nephrotoxicity

Pulse wave velocity as index of arterial stiffness in HIV-infected patients compared with a healthy population

Quality of life, emotional status, and adherence of HIV-1-infected patients treated with efavirenz versus protease inhibitor-containing regimens

Randomised study to assess the efficacy and safety of once-daily etravirine-based regimen as a switching strategy in HIV-infected patients receiving a protease inhibitor-containing regimen. Etraswitch study

Removal of Dolutegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease

Role of structured treatment interruption before a 5-drug salvage antiretroviral regimen: the Retrogene Study.

Significant improvement in triglyceride levels after switching from ritonavir to cobicistat in suppressed HIV-1-infected subjects with dyslipidaemia

Switching from a ritonavir-boosted PI to dolutegravir as an alternative strategy in virologically suppressed HIV-infected individuals.

Switching from tenofovir to abacavir in HIV-1-infected patients with low bone mineral density: changes in bone turnover markers and circulating sclerostin levels.

Switching the third drug of antiretroviral therapy to maraviroc in aviraemic subjects: a pilot, prospective, randomized clinical trial

Targeting only reverse transcriptase with zidovudine/lamivudine/abacavir plus tenofovir in HIV-1-infected patients with multidrug-resistant virus: a multicentre pilot study.

Ten-Year Safety with Polyacrylamide Gel Used to Correct Facial Lipoatrophy in HIV-Infected Patients

Time of progression to osteopenia/osteoporosis in chronically HIV-infected patients: screening DXA scan

Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiated.

Validation of estimated renal function measurements compared with the isotopic glomerular filtration rate in an HIV-infected cohort

Variable endothelial cell function restoration after initiation of two antiretroviral regimens in HIV-infected individuals

Viral failure in HIV-infected patients with long-lasting viral suppression who discontinued enfuvirtide

Virological, immunological, and clinical impact of switching from protease inhibitors to nevirapine or to efavirenz in patients with human immunodeficiency virus infection and long-lasting viral suppression